Financing ·
SciSparc offers to convert $2.02M convertible note into shares at $1.50 per share
SPRCSciSparc Ltd.
On October 15, 2026, SciSparc Ltd. entered into an inducement offer letter agreement with L.I.A Pure Capital Ltd., the holder of a convertible promissory note issued on February 12, 2026. The company offered to convert the outstanding principal and accrued interest totaling $2,023,039.21 into ordinary shares at a conversion price of $1.50 per share. No additional cash payment is required from the holder, and SciSparc will not receive any cash proceeds from the transaction. The closing is expected to occur on or about October 16, 2026. SciSparc Ltd. operates in the medical technology industry, developing diagnostic devices for infectious diseases.